What is the difference between neoadjuvant and adjuvant treatment?

The difference is timing, and the National Cancer Institute defines both terms in the same breath. Chemotherapy that makes a tumor smaller before surgery or radiation therapy is called neoadjuvant chemotherapy. Chemotherapy that destroys cancer cells which may remain after surgery or radiation is called adjuvant chemotherapy.

The words mark a position, not a drug

That is the part people find slippery. The same drug, at the same dose, is neoadjuvant when it runs before the main treatment and adjuvant when it runs after. Nothing about the drug changed. Only its place in the order did.

The terms are not reserved for chemotherapy either, even though that is where most people first hear them. NCI uses identical language for hormone therapy: it can make a tumor smaller before surgery or radiation, called neoadjuvant therapy, or lower the risk that cancer comes back after the main treatment, called adjuvant therapy.

NCI also lists two other jobs those treatments do, which fit neither label. They can help other treatments work better. And they can kill cancer cells that have returned or spread to other parts of the body.

Which part counts as the main treatment

The labels only make sense once that is settled. Usually the main treatment is surgery. For some cancers it is radiation therapy, or radiation and chemotherapy together.

So the first question to ask about a treatment plan is which part is the anchor. Every other label hangs off it. NCI notes that most people with cancer have a combination of treatments rather than one, and that what they receive depends on the type of cancer and how advanced it is.

What going first lets the team see

Running treatment before surgery has one advantage that running it afterward cannot offer.

While the tumor is still in place, its response can be measured. Scans and exams show whether it is shrinking. A tumor that shrinks is direct evidence the treatment is working on that particular cancer. A tumor that does not gives the team a reason to change course early.

Once the tumor has been removed there is nothing left to measure. Adjuvant treatment is therefore given on the basis of risk rather than visible response, which is why the reasoning behind it can feel more abstract.

Neoadjuvant treatment has a second purpose NCI states plainly: making the tumor smaller before the operation. Our guide to how chemotherapy is given covers the practical side, and questions to ask before cancer treatment begins covers what to establish about sequence.

Both is normal

Plenty of people get both. A common pattern is treatment first, then surgery, then more treatment afterward.

Whether a plan includes one, the other, or both depends on the type of cancer and how advanced it is. That is a decision for the treating team, and it is worth asking to hear the reasoning rather than only the schedule.

Three questions make the conversation concrete. Which part of this plan is the main treatment? For each of the other parts, is it neoadjuvant or adjuvant, and what is it meant to achieve? And does the plan change if the first stage does not go as hoped?

The third question matters most for neoadjuvant treatment, because that is the stage where an early answer is actually available.

NCI's chemotherapy page was last updated on May 15, 2025, and its hormone therapy page on the same date.

Sources

• https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
• https://www.cancer.gov/about-cancer/treatment/types/hormone-therapy